CHARCOT-MARIE-TOOTH DISEASE TYPE 2

Clinical trials for CHARCOT-MARIE-TOOTH DISEASE TYPE 2 explained in plain language.

Never miss a new study

Get alerted when new CHARCOT-MARIE-TOOTH DISEASE TYPE 2 trials appear

Sign up with your email to follow new studies for CHARCOT-MARIE-TOOTH DISEASE TYPE 2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New drug shows promise for nerve disease that affects walking

Symptom relief Completed

This study tested a new medicine called NMD670 in 81 adults with Charcot-Marie-Tooth disease types 1 and 2. Participants took either the drug or a placebo twice daily for 21 days. The main goal was to see if the drug could improve walking distance in 6 minutes. The study also che…

Matched conditions: CHARCOT-MARIE-TOOTH DISEASE TYPE 2

Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Symptom relief

Last updated Jun 27, 2026 07:57 UTC

CHARCOT-MARIE-TOOTH DISEASE TYPE 2

Get alerted when new CHARCOT-MARIE-TOOTH DISEASE TYPE 2 trials appear

New drug shows promise for nerve disease that affects walking